Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: A randomized double-blind placebo-controlled clinical trial

Phytotherapy Research

Volumn 25, Issue 12, 2011, Pages 1849-1853

  Kianbakht, S ^a   Abasi, B ^b   Perham, M ^c   Hashem Dabaghian, F ^d  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b Diabetes Clinic   (Iran)

^c QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

antihyperlipidemic; hyperlipidemia; patient; sage; Salvia officinalis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PLACEBO; SALVIA OFFICINALIS EXTRACT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PLANT LEAF; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

ADULT; CHOLESTEROL; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; SALVIA OFFICINALIS; YOUNG ADULT;

EID: 82155197276     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3506     Document Type: Article

References (27)

1. Alcaraz M, Acevedo C, Castillo J, et al,. 2009. Liposoluble antioxidants provide an effective radioprotective barrier. Br J Radiol 82: 605-609.
2. Backes JM, Gibson CA, Howard PA,. 2005. Optimal lipid modification: the rationale for combination therapy. Vasc Health Risk Manag 1: 317-331.
3. Burnett JR, Watts GF,. 2007. MTP inhibition as a treatment for dyslipidemias: time to deliver or empty promises? Expert Opin Ther Targets 11: 181-189. (Pubitemid 46188813)
4. D'Amelio Sr. FS,. 1999. Botanicals: A Phytocosmetic Desk Reference. CRC Press: New York.
5. Davidson MH, Toth PP,. 2004. Comparative effects of lipid-lowering therapies. Prog Cardiovasc Dis 47: 73-104. (Pubitemid 39600944)
6. Eckel RH,. 2010. Approach to the patient who is intolerant of statin therapy. J Clin Endocrinol Metab 95: 2015-2022.
7. Eidi M, Eidi A, Zamanizadeh H,. 2005. Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozocin-induced diabetic rats. J Ethnopharmacol 100: 310-313. (Pubitemid 41206627)
8. Fugh-Berman A,. 2000. Herbs and dietary supplements in the prevention and treatment of cardiovascular disease. Prev Cardiol 3: 24-32. (Pubitemid 30217399)
9. Gilde AJ, Fruchart JC, Staels B,. 2006. Peroxisome proliferator-activated receptors at the crossroads of obesity, diabetes, and cardiovascular disease. J Am Coll Cardiol 48: A24-A32. (Pubitemid 44648644)
10. Gross B, Staels B,. 2007. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 21: 687-710. (Pubitemid 350177568)
11. Guerin M, Egger P, Le Goff W, et al,. 2002. Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia. J Clin Endocrinol Metab 87: 4991-5000. (Pubitemid 35316337)
12. Huang THW, Kota BP, Razmovski V, et al,. 2005. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol 96: 3-14. (Pubitemid 40260842)
13. Koh KK, Quon MJ, Rosenson RS, et al,. 2008. Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statin and fibrates. Int J Cardiol 124: 149-159. (Pubitemid 351173369)
14. Lima CF, Azevedo MF, Araujo R, et al,. 2006. Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention? Br J Nutr 96: 326-333. (Pubitemid 46470100)
15. Low Dog T,. 2006. A reason to season: the therapeutic benefits of spices and culinary herbs. Explore (NY) 2: 446-449.
16. Ninomiya K, Matsuda H, Shimoda H, et al,. 2004. Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg Med Chem Lett 14: 1943-1946. (Pubitemid 38410869)
17. Oboh G, Henle T,. 2009. Antioxidant and inhibitory effects of aqueous extracts of Salvia officinalis leaves on pro-oxidant-induced lipid peroxidation in brain and liver in vitro. J Med Food 12: 77-84.
18. Oniga I, Parvu AE, Toiu A, et al,. 2007. Effects of Salvia officinalis L. extract on experimental acute inflammation. Rev Med Chir Soc Med Nat Lasi 111: 290-294.
19. Pahan K,. 2006. Lipid-lowering drugs. Cell Mol Life Sci 63: 1165-1178. (Pubitemid 43939003)
20. Rau O, Wurglics M, Paulke A, et al,. 2006. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med 72: 881-887. (Pubitemid 44378949)
21. Sa CM, Ramos AA, Azevedo MF, et al,. 2009. Sage tea drinking improves lipid profile and antioxidant defenses in humans. Int J Mol Sci 10: 3937-3950.
22. Staels B, Fruchart JC,. 2005. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54: 2460-2470. (Pubitemid 41134276)
23. Stocks N, Allan J, Mansfield PR,. 2005. Management of hyperlipidemia. Aust Fam Physician 34: 447-452.
24. Tapsell LC, Hemphill I, Cobiac L, et al,. 2006. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185: S4-S24.
25. Tenenbaum A, Fisman EZ, Motro M, et al,. 2008. Optimal management of combined dyslipidemia: what have we behind statins monotherapy? Adv Cardiol 45: 127-153.
26. The United States Pharmacopoeial Convention. 2004. USP, 28th edn. Webcom Limited: Toronto.
27. Zargari A., 1997. Medicinal Plants, 4th edn. Tehran University Publications: Tehran.